People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Pharmaceuticals, Other Technology, Other, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aratana Therapeutics, Inc. | — | Pharmaceuticals | Series B | $67.3M | $1.0B | 2010 |
| eNeura, INC. | — | Other Technology | Series A | $53.6M | $14.2M | 2012 |
| H.O.P. Entertainment, LLC | — | Other | Series A | $8.5M | $128.6M | 2011 |
| Aruene Corp | — | Other Health Care | Seed | $6.0M | $21.1M | 2021 |
| Amplifica Holdings Group, Inc. | — | Biotechnology | Seed | $2.7M | $44.0M | 2022 |
| Velo-1, Inc. | — | Other Health Care | Seed | $2.5M | $7.0M | 2025 |
| Waveseer of Illinois, LLC | — | Other Health Care | Pre-Seed | $675K | $20.8M | 2014 |
| Waveseer, LLC | — | Other Health Care | Pre-Seed | $250K | $7.7M | 2014 |
| Waveseer of Las Vegas, LLC | — | Other Health Care | Pre-Seed | $200K | $6.2M | 2014 |
| Waveseer of Oregon, LLC | — | Other Health Care | Pre-Seed | $150K | $4.6M | 2015 |
David Rosen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Rosen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.